MENU
ATYR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
aTyr Pharma (ATYR) Ownership - Who owns aTyr Pharma?
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
471.72M
P/E Ratio
N/A
Total Cash
76.35M
Projected Growth
N/A
Total Debt
12.99M
Revenue
N/A
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash/Share
0.86
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ATYR
Capitalization
472M
P/E Ratio
N/A
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash
76.3M
Total Cash/Share
0.86
Total Debt
13M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
75M
P/B Ratio
6.30
Cash Flow
N/A
Earnings
-0.8
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
89K
Current Ratio
7.79
Current Revenue Per Employee
3983.05
Dividends Per Share - Security
N/A
EBITDA
-65.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-60.25
Shares Held By Institutions
378M
Shares Outstanding - Current
89M
Total Liabilities
22.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
44.751
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATYR showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information